159 filings
Page 2 of 8
8-K
dg8nf
27 Dec 22
Departure of Directors or Certain Officers
4:27pm
8-K
xmwyyx jriua
6 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:12pm
8-K
k2teq121g8pivgxtee
1 Nov 22
Blueprint Medicines Outlines 2027 Blueprint to Achieve Precision Medicine at Scale
8:08am
8-K
4q8oix5f
23 Sep 22
Departure of Directors or Certain Officers
5:28pm
8-K
og8mp63ymisrsurtt6
7 Sep 22
Regulation FD Disclosure
4:21pm
8-K
q9v zn96mbgl1dcm6mq4
17 Aug 22
Other Events
7:28am
8-K
ki8 39z6ze1
2 Aug 22
Blueprint Medicines Reports Second Quarter 2022 Results
7:47am
8-K
mp9ef9
30 Jun 22
Blueprint Medicines Announces Transformative $1.25 Billion Strategic Financing Collaborations with Sixth Street and Royalty Pharma
4:05pm
8-K
dh76o0ban8i38f 9yk
27 Jun 22
Departure of Directors or Certain Officers
4:15pm
8-K
zb4b gi2l53t
23 Jun 22
Blueprint Medicines Appoints Habib Dable to its Board of Directors
4:33pm
8-K
5dn92 j2bdb7s
9 Jun 22
Regulation FD Disclosure
7:40am
8-K
et791fkbf4yih41y
3 May 22
Blueprint Medicines Reports First Quarter 2022 Results
7:45am
8-K
dg1ey7ojzc2e9g1lvgth
29 Apr 22
Regulation FD Disclosure
8:00am
8-K
sdseexhb056yf
8 Apr 22
Regulation FD Disclosure
1:20pm
8-K
a19z2weyc z8jz3uv
28 Feb 22
Blueprint Medicines and Proteovant Therapeutics Announce Strategic Collaboration to Advance Novel Targeted Protein Degrader Therapies
8:26am
8-K
ufciepovw8 it
16 Feb 22
Blueprint Medicines Reports Fourth Quarter and Full Year 2021 Results
7:21am
8-K
1vzka zxm5
20 Jan 22
Blueprint Medicines Elevates Two Talented Leaders to its Executive Team
8:08am
8-K
mosbuon1fugdqmv
10 Jan 22
Regulation FD Disclosure
8:27am
8-K
erkdd6
5 Jan 22
Blueprint Medicines Announces CEO and Leadership Transition Plan
8:07am
8-K
4xw9mx6w
30 Dec 21
Blueprint Medicines Completes Acquisition of Lengo Therapeutics
9:11am